HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No. 10, October 2020 – Artificial Intelligence Technologies — Helping the Fight Against COVID-19s       » Improving Sensitivity of Optical Receivers for Space Communication       » Genetic Variants Identified for the Susceptibility to Neuroblastoma       » Novo Nordisk Launches New Treatment for Diabetes in Singapore       » SMART Researchers Find New Way to Make Bacteria More Sensitive to Antibiotics       » Study Finds Liver Injury to be Common Among COVID-19 Patients      
NEWS CRUNCH
Lite-On presents a new Biomedical Research and Development Centre in Singapore
(Photo credit to Lite-On)

It will be the company's first overseas biomedical R&D center with a focus on in-vitro diagnostics.

Singapore, March 2, 2016 - Lite-On Group today announced that it will set up its first overseas biomedical Research & Development centre in Singapore. As a leading company in the opto-electronic components industry, this is the next step in their expansion plans, and Lite-On Medical targets to put in an accumulated investment of SGD 40 million by 2018.

With its headquarters in Taiwan, Lite-On has been serving customers from the Communication, Computer, Consumer Electronics, LED Lighting, Cloud Computing and Automotive industries, and expanded its business scope to medical devices by developing innovative In-Vitro Diagnostics (IVD) products under the brand skyla?. Launched in 2011, it has been highly successful world-wide since then.

The new R&D center aims to leverage on Singapore's clinical strengths and talented medical research professionals and Lite-On's extensive expertise in system design and manufacturing innovative point-of-care (POC) medical devices to fulfil unmet market needs in emergency care, telemedicine and decentralized healthcare service. In addition, the biomedical R&D centre plans to hire 40 highly-skilled staff in 2016.

With this new launch of the R&D centre, Lite-On wants to provide its innovative product designs and manufacturing ability to the Singapore healthcare industry, to help it gain a highly competitive advantage with their range of technical entry barrier products.

"We know that the Singapore government is committed to invest in the development of biomedical industry. Besides this strong support, the country's economic stability, the well-known protection of intellectual property assets and high-quality manpower, all of these attracted us to set up our first overseas biomedical R&D center here" says Mr. Danny Liao, Group New Business CEO, Lite-On Group.

For more information, please email LiteOnSG@hoffman.com or call 63610252.

About Lite-On Group

Established in 1975, Lite-On Technology Corporation, a leading global organization and major player in optoelectronic components industry, envisions to be the best partner in opto-electronic, eco-friendly and intelligent technologies. The company serves customers from Communication, Computer, Consumer Electronics, LED Lighting, Cloud Computing and Automotive. In addition to the above industries, Lite-On has expanded its business scope to Medical Device by developing innovative IVD products since 2011, with the brand name of skyla?. The Biomedical sector will become the next growth driver for Lite-On group.

Source: Lite-On Group & The Hoffman Agency
NEWS CRUNCH  
news PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
news PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products
news Singapore Biomedical Company Appointed as a Certified Service Provider by 10x Genomics
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Grou
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy